Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 0/25
Result 14,863 decisions over 12 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
20 Oct 2025
10% owner indirect
Sold on a plan
220,535
$1.37M
1.4%
20 Oct 2025
Senior EVP and General Counsel
Sold at will
26,909
$1.26M
10.6%
20 Oct 2025
Director indirect
Sold on a plan 6×
7,665
$1.21M
2.0%
20 Oct 2025
CEO, Co-Founder indirect
Sold on a plan 6×
7,665
$1.21M
2.0%
17 Oct 2025
10% owner
Bought
643,850
$258.83B
opened
17 Oct 2025
10% owner indirect
Sold at will 36×
262,574
$35.87M
45.5%
17 Oct 2025
Director
Sold on a plan 4×
64,426
$14.73M
0.0%
17 Oct 2025
President and CEO
Sold on a plan 5×
75,000
$13.67M
0.1%
17 Oct 2025
President & CEO
Sold at will 10×
2,533
$10.18M
97.9%
17 Oct 2025
Executive Chairman
Sold at will 4×
40,000
$8.31M
3.1%
17 Oct 2025
Director indirect
Sold at will 6×
260,859
$7.67M
94.5%
17 Oct 2025
Director indirect
Sold at will 14×
70,000
$6.22M
15.4%
17 Oct 2025
President and CEO
Sold on a plan
21,367
$4.44M
7.0%
17 Oct 2025
President and CTO
Sold on a plan 5×
30,000
$4.28M
69.8%
17 Oct 2025
EVP, Innovative Medicine, R&D
Sold at will
21,721
$4.19M
67.1%
17 Oct 2025
10% owner indirect
Bought
81,855
$4.04M
1.7%
17 Oct 2025
10% owner
Sold at will
980,000
$3.98M
7.9%
17 Oct 2025
President and CTO indirect
Sold on a plan 10×
26,000
$3.71M
4.5%
17 Oct 2025
Chief Executive Officer
Sold at will
50,895
$3.46M
16.7%
17 Oct 2025
Director indirect
Sold at will
250,000
$3.28M
1.0%
17 Oct 2025
President and CEO indirect
Sold on a plan
596,356
$3.20M
8.3%
17 Oct 2025
Director
Sold on a plan
62,000
$2.78M
34.0%
17 Oct 2025
President & Immunovant CEO
Sold on a plan
118,418
$2.02M
7.3%
17 Oct 2025
Director indirect
Sold on a plan 6×
61,124
$1.98M
7.9%
17 Oct 2025
Chief Legal Officer
Sold on a plan 2×
52,777
$1.82M
9.5%
17 Oct 2025
Chairperson & CEO
Sold on a plan 2×
4,000
$1.72M
96.9%
17 Oct 2025
10% owner
Sold on a plan 2×
16,559
$1.40M
0.2%
17 Oct 2025
President & CEO
Sold at will
21,883
$1.20M
7.5%
17 Oct 2025
Director
Bought
12,000
$1.16M
69.2%
17 Oct 2025
Director indirect
Sold on a plan 3×
7,665
$1.16M
1.9%
17 Oct 2025
CEO, Co-Founder indirect
Sold on a plan 3×
7,665
$1.16M
1.9%
16 Oct 2025
10% owner indirect
Sold at will 108×
2,110,891
$302.94M
87.0%
16 Oct 2025
President & CEO indirect
Sold on a plan
12,500
$232.81M
0.2%
16 Oct 2025
10% owner indirect
Bought 10×
313,910
$33.20M
15.3%
16 Oct 2025
Director
Sold on a plan 5×
64,426
$14.63M
0.0%
16 Oct 2025
10% owner indirect
Sold at will
102,261
$14.32M
3.5%
16 Oct 2025
President and CEO
Sold on a plan 4×
75,000
$13.63M
0.1%
16 Oct 2025
CEO & Board Co-Chair indirect
Sold on a plan 12×
52,384
$11.21M
100%
16 Oct 2025
10% owner indirect
Sold at will 2×
535,843
$10.89M
0.9%
16 Oct 2025
Chief Executive Officer
Sold on a plan 7×
128,127
$8.04M
58.1%
16 Oct 2025
Founder and Chief Architect
Sold on a plan
25,000
$6.15M
33.1%
16 Oct 2025
Director indirect
Sold on a plan 8×
169,260
$5.48M
19.0%
16 Oct 2025
President & Immunovant CEO
Sold on a plan
318,282
$5.43M
17.5%
16 Oct 2025
Director indirect
Sold at will
400,000
$5.06M
1.6%
16 Oct 2025
EVP & GENERAL COUNSEL
Sold on a plan 8×
11,000
$4.75M
23.0%
16 Oct 2025
President and CEO
Sold on a plan 2×
21,355
$4.60M
7.0%
16 Oct 2025
Director indirect
Sold at will 6×
151,803
$4.47M
72.4%
16 Oct 2025
Chief Tech &Transformation Off
Sold at will
230,000
$4.43M
43.3%
16 Oct 2025
President and CEO indirect
Sold on a plan
596,356
$3.14M
7.7%
16 Oct 2025
Chief Executive Officer indirect
Sold on a plan 2×
47,534
$2.99M
50.0%
Showing 14,201–14,250 of 14,863. ← Newer Page 285 of 298 Older →